IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancerNadine Bley, Stefan Hüttelmaier, Annekatrin Schott et al.|RNA Biology|2020Cited by 55
Chemoradiation in Cervical Cancer with Cisplatin and High-Dose Rate Brachytherapy Combined with External Beam RadiotherapyHans‐Georg Strauß, G. Haensgen, Thomas Kuhnt et al.|Strahlentherapie und Onkologie|2002Cited by 53
Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome DatabaseMev Dominguez–Valentin, Emma J. Crosbie, Eivind Hovig et al.|Journal of Clinical Medicine|2020Cited by 23
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancerNadine Bley, Stefan Hüttelmaier, Annekatrin Schott et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 7